Additionally, Li et al. found that the injection of recombinant human HGF promotes the phosphorylation of JAK2-STAT3 in mouse liver and inhibits inflammation, thereby enhancing liver function in mice with non-alcoholic fatty liver disease [10]. Here, HGF is linked to metabolic dysfunction-associated steatotic liver disease.